Why is Ind-Swift Labs. falling/rising?

As of 01-Jul, Ind-Swift Laboratories Ltd is currently priced at 112.30, reflecting a slight increase of 0.3, or 0.27%. The stock has shown a positive performance today, outperforming its sector by 0.48% and marking its second consecutive day of gains with a total return of 2.19% over this period. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Despite a year-over-year decline of 16.75%, the stock has seen a significant 36.95% increase over the past month, supported by rising investor participation, as evidenced by an 8.07% increase in delivery volume compared to the 5-day average. However, the company has not declared results in the last six months, and its high Debt to EBITDA ratio of 3.81 times raises concerns about its long-term fundamental strength.
In the broader market context, the stock's short-term performance of +4.35% over the past week significantly outpaces the Sensex, which has only increased by 2.00% during the same period. While the stock has underperformed the market over the past year, the recent uptick in institutional investor participation, with a 2.59% increase in their stake, suggests a growing confidence among more sophisticated investors. This could be a positive indicator for future performance, despite the company's recent negative financial results, including a drastic fall in net sales and profitability issues. Overall, while there are positive short-term indicators, the long-term outlook remains clouded by fundamental weaknesses.